 |
Welcome
iDGFM
Clinical Evidence
Clinical Education
US Reimbursement
Investor Relations
Latest News
Contact Us
|
|
CardioQ–ODM™ reduces lengths of stay in Spain by six days 06 November 2008 Deltex Medical Group plc ("Deltex Medical"), the UK's leading haemodynamic monitoring companyand global leader in oesophageal Doppler monitoring ("ODM"), announces today the results of a multi-centre audit of the CardioQ–ODM™ in Spain. Over 3,000 surgeons at the Congreso Nacional de Cirugia in Madrid heard the first findings of the eleven hospitals to have collated data on the impact of introducing CardioQ–ODM™ as part of an enhanced recovery programme in colorectal surgery. Dr Ramirez, the lead colorectal surgeon from Hospital General Universitario Zaragoza, reported that the average (mean) length of stay had been reduced by six days per patient. After the introduction of CardioQ–ODM™ as part on an enhanced recovery protocol, patients were discharged after six days, whereas previously they had stayed in hospital for twelve days. The results of the audit are being studied by representatives of the Entralgo Agency, which makes recommendations to the Spanish healthcare system about the clinical and cost effectiveness of medical innovations. A draft health technology assessment by this Agency, based on results from UK randomised controlled trials, indicated that using the CardioQ–ODM™ would save €900 per patient, reduce mortality rates and significantly reduce complications: the draft conclusions, although contingent on outcomes from the above audit, were already assessed as "robust". Deltex Medical's Chief Executive, Andy Hill commented: "These results confirm that we have created a major opportunity to establish a very large, high quality business in Spain. The country's leading surgeons are recommending new packages of care with ODM as the key single innovation and they are already looking beyond colorectal surgery to other types of major surgery. The Spanish government agencies that determine funding priorities have been involved throughout the audit and should now be able to finalise their positive draft health technology assessment and recommend ODM as a standard of care." For further information, please contact: Deltex Medical Group plc 01243 774 837 Gavin Anderson & Company 020 7554 1400 Charles Stanley Securities 020 7149 6000
|